Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127891691 | 12789169 | 1 | I | 20160727 | 20160923 | 20160928 | 20160928 | EXP | GB-MHRA-TPP24080327C1860021YC1469606037611 | GB-SA-2016SA177582 | AVENTIS | 84.00 | YR | E | M | Y | 89.00000 | KG | 20160928 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127891691 | 12789169 | 1 | PS | INDAPAMIDE. | INDAPAMIDE | 1 | Oral | Y | U | 18538 | 2.5 | MG | |||||||
| 127891691 | 12789169 | 2 | C | AMITRIPTYLINE HYDROCHLORIDE. | AMITRIPTYLINE HYDROCHLORIDE | 1 | AT NIGHT. | 1800 | 0 | 50 | MG | QD | |||||||
| 127891691 | 12789169 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 41 | 0 | 1 | DF | QD | ||||||||
| 127891691 | 12789169 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | AT NIGHT | 36 | 0 | 1 | DF | QD | |||||||
| 127891691 | 12789169 | 5 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | TWICE DAILY. | 0 | 2 | DF | |||||||||
| 127891691 | 12789169 | 6 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 36 | 0 | 1 | DF | QD | ||||||||
| 127891691 | 12789169 | 7 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | 144 | 0 | 2 | DF | BID | ||||||||
| 127891691 | 12789169 | 8 | C | LACTULOSE. | LACTULOSE | 1 | TWICE DAILY. | 0 | 15 | ML | |||||||||
| 127891691 | 12789169 | 9 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | EACH MORNING. | 3600 | 0 | 100 | UG | QD | |||||||
| 127891691 | 12789169 | 10 | C | PARACETAMOL | ACETAMINOPHEN | 1 | TAKE 1 OR 2, 4 TIMES A DAY. | 0 | TABLET | ||||||||||
| 127891691 | 12789169 | 11 | C | PREGABALIN. | PREGABALIN | 1 | 100 MG IN THE MORNING AND 150 MG AT NIGHT | 18000 | 0 | 250 | MG | BID | |||||||
| 127891691 | 12789169 | 12 | C | RAMIPRIL. | RAMIPRIL | 1 | IN THE EVENING | 360 | 0 | 10 | MG | QD | |||||||
| 127891691 | 12789169 | 13 | C | SALBUTAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | 0 | 2 | DF | |||||||||
| 127891691 | 12789169 | 14 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127891691 | 12789169 | 5 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127891691 | 12789169 | HO |
| 127891691 | 12789169 | LT |
| 127891691 | 12789169 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127891691 | 12789169 | Confusional state | |
| 127891691 | 12789169 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127891691 | 12789169 | 1 | 20160727 | 0 | ||
| 127891691 | 12789169 | 2 | 20160621 | 0 | ||
| 127891691 | 12789169 | 3 | 20160616 | 0 | ||
| 127891691 | 12789169 | 4 | 20160621 | 0 | ||
| 127891691 | 12789169 | 5 | 20160621 | 0 | ||
| 127891691 | 12789169 | 6 | 20160621 | 0 | ||
| 127891691 | 12789169 | 7 | 20160621 | 0 | ||
| 127891691 | 12789169 | 8 | 20160621 | 0 | ||
| 127891691 | 12789169 | 9 | 20160621 | 0 | ||
| 127891691 | 12789169 | 10 | 20160621 | 0 | ||
| 127891691 | 12789169 | 11 | 20160621 | 0 | ||
| 127891691 | 12789169 | 12 | 20160621 | 0 | ||
| 127891691 | 12789169 | 13 | 20160621 | 0 |